In Germany, the revenue in the Cold & Cough Remedies market market is estimated to reach US$2.06bn by 2024. It is projected to grow at an annual rate of 4.72% between 2024 and 2029 (CAGR 2024-2029).
The study focused on assessing oral nalbuphine extended release for cough relief in idiopathic pulmonary fibrosis patients. A randomized, double-blind, placebo-controlled trial design was employed ...